Varian Medical Systems, Inc. (VAR)

132.49
2.02 1.55
NYSE
Prev Close 130.47
Open 130.90
Day Low/High 130.48 / 132.54
52 Wk Low/High 101.42 / 134.99
Volume 110.73K
Exchange NYSE
Shares Outstanding 90.78B
Market Cap 11.87B
Div & Yield N.A. (N.A)
Varian Medical's Profit Climbs

Varian Medical's Profit Climbs

Robust demand boosts revenue and the bottom line.

Cramer's 'Mad Money Lightning Round': Hey St. Jude

Cramer's 'Mad Money Lightning Round': Hey St. Jude

Boston Sci's expected stent-sales shortfall should make St. Jude a cheaper play.

Cramer's 'Mad Money' Recap: Get In the GameStop

Cramer's 'Mad Money' Recap: Get In the GameStop

Even though EA has the wildly popular Madden NFL game, GameStop is better positioned, says Cramer.

Cramer's 'Mad Money Lightning Round': Barr None

Cramer's 'Mad Money Lightning Round': Barr None

Cramer says Merck, Pfizer and Schering-Plough are all better than Barr Pharma.

Varian Medical Taps Vice President

Varian Medical Taps Vice President

Tai-Yun Chen was controller.

RealMoney's Best Blogs

The week's highlights from the site's five bloggers: Jim Cramer, Rev Shark, Cody Willard, Steve Smith and Tony Crescenzi.

Cramer's 'Mad Money' Recap: Tricking Terror

Cramer goes against the herd when it comes to playing the market after a terrorist threat.

RealMoney Radio: Market Muscle

Cramer says stocks are resilient to the news of a foiled terrorist plot.

RealMoney Radio Recap: Cyclical Fear

RealMoney Radio Recap: Cyclical Fear

Cramer says you still need to stay away from stocks that have exposure to the economy.

RealMoney Radio: All's Wellness at Philips

RealMoney Radio: All's Wellness at Philips

Cramer sees a merger with Varian, an oncology radiation company.

Cramer's 'Mad Money' Recap: A Muzzle for Talking Heads

Cramer's 'Mad Money' Recap: A Muzzle for Talking Heads

Cramer offers a lesson on diagnostics to help investors pick stocks like the pros.

Cramer's 'Mad Money Lightning Round': A Good Prognosis for Varian Medical

Cramer's 'Mad Money Lightning Round': A Good Prognosis for Varian Medical

Cramer didn't mince words when it came to this stock.

Varian Medical Gets U.K. Contract

A cancer-care upgrade results in a machine order.

Today's Health Winners and Losers

Pharmacopeia gets a big lift after announcing a drug discovery pact with Cephalon.

Varian Medical Earnings Rise

Shares fall 2%.

Markets Finally Decide to Follow Pattern

The cycle we've seen since late November implies we'll see a pullback of two to three weeks.

Market May Have Squandered a Chance

Instead of vaulting old highs on good Arms Index numbers, indices have been reluctant to get going.

Varian Medical Gets Bangladesh Pact

Varian Medical Gets Bangladesh Pact

Public hospitals will get four linear accelerators.

Today's Health Winners and Losers

Alexion jumps on positive trial results, while CNS falls after a weak profit report.

Varian Medical Beats Forecast

Profits rose 2% from a year ago.

Cramer's 'Mad Money' Recap: Collecting on Debt

A recent rash of new bankruptcy filings is good news for Portfolio Recovery Associates, says Cramer.

Cramer's 'Mad Money Lightning Round': Not Calling Avon

Also, Banco Bradesco is muy caliente.

Cramer's 'Mad Money' Recap: Total Eclipse

Cramer says the French oil company is a celestial buy. Also, the eve of construction.

Cramer's 'Mad Money' Recap: GE a Good Thing for Stocks

Strength in the conglomerate's divisions should have sector ripple effects, Cramer says.

Chip Traders Keep Cool

Bulls stay the course as semiconductor stocks sell off for the second day in a row.

A Bushel Full for Bush's Next Four Years

A Bushel Full for Bush's Next Four Years

Energy and defense for sure, but commodities, utilities and even two Internet stocks make it.

Varian Medical Soars on Outlook

Varian Medical Soars on Outlook

The medical equipment company says order growth in its oncology business has been strong.

Varian Falls on Order Data

Varian Falls on Order Data

Investors ignore a better-than-expected third-quarter outlook.

Standoff in Oversold Territory Favors Bears

It's a good time to raise cash. Also, charts of Coors, Qualcomm and others.

Waiting for the Next
Big Move

As the larger indices bounce within channels, many stocks aren't moving with the market.

TheStreet Quant Rating: A (Buy)